Abstract
The steady increase in complete remission rates for patients with acute myeloblasts leukaemia which was achieved in the 1960’s with the advent of new cytotoxic agents has now reached a plateau. Major efforts have been devoted to attempts to prolong complete remission with immunotherapy, and several clinical trials using BCG as immunotherapy have shown encouraging results.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baldwin, R. W., Pimm, M. V.: B.C.G. immunotherapy of pulmonary growths from intravenously transferred rat tumour cells. Brit. J. Cancer 27, 48–54 (1973).
Currie, G. A., Bagshawe, K. D.: Active immunotherapy with corynebacterium parvum and chemotherapy in murine fibrosarcomas. Brit. Med. J. 1, 541–544 (1970).
Gutterman, J. U., Hersh, E. M., Rodriguez, V., McCredie, K. B., Mavligit, G., Reed, R., Burgess, M. A., Smith, T., Gehan, E., Bodey, G. P., Freireich, E. J.: Chemoimmunotherapy of adult acute leukaemia; prolongation of remission in myeloblastic leukaemia with B.C.G. Lancet (1974) II, 1405–1409.
Mathé, G., Amiel, J. L., Schwarzenberg, L., Schneider, M., Cattan,A., Schlumberger, J. R., Hayat, M., De Vassal, F.: Active immunotherapy in acute lymphoblastic leukaemia. Lancet (1969) I, 697–699.
Mathé, G., Schwarzenberg, L., Simmler, M. C., Jurczyk-Procyk, S.: Intravenous B.C.G. in monkey and man. Lancet (1976) I, 92.
McKhann, C., Gunnarsson, A. In: Neoplasm Immunity. Crispen, R. G. (ed.). Illinois: Evanston, 1974, p. 31.
Milas, L., Gutterman, J. U., BaSic, I., Hunter, N., Mavligit, G. M., Hersh, E. M., Withers, H. R.: Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. Granulosum and C. Parvum. Inter. J. Cancer 14, 493–503 (1974).
Muggleton, P. W., Prince, G. H., Hilton, M. L.: Effect of intravenous B.C.G. in guineapigs and pertinence to cancer immunotherapy in man. Lancet (1975) I, 1353–1355.
Pearson, J. W., Pearson, G. R., Gibson, W. T., Chermann, J. C., Chirigos, M. A.: Combined chemoimmunostimulation therapy against murine leukaemia. Cancer Res. 32, 904–907 (1972).
Spitler, L. E., Wybran, J., Lieberman, R., Levinson, D., Epstein, W., Hendrickson, C. : Neoplasm Immunity. Crispen, R. G. (ed.). Illinois: Evanston, 1974, p. 45.
Vogler, W. R., Chan, Y-K.: Prolonging remission in myeloblastic leukaemia by tice-strain bacillus calmette-guerin. Lancet (1974) II, 128–131.
Whittaker, J. A., Lilleyman, J. S., Jacobs, A., Balfour, I: Immunotherapy with intravenous B.C.G. Lancet (1973) II, 1454.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Whittaker, J.A. (1977). Chemotherapy and Immunotherapy Interspersion: Clinical Studies in Acute Myeloblastic Leukaemia. In: Mathé, G. (eds) Tactics and Strategy in Cancer Treatment. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 62. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81174-6_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-81174-6_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81176-0
Online ISBN: 978-3-642-81174-6
eBook Packages: Springer Book Archive